How the International Association of Gerontology and Geriatrics Approaches the Challenge of Managing Multiple Chronic Conditions in Older Adults

The world is aging at a pace that health systems were never designed to handle. By 2050, the number of people aged 60 and over is projected to exceed two billion globally—more than double today’s figure. With this demographic shift comes a clinical reality that defines modern geriatric medicine: the majority of older adults do not live with a single chronic illness. They live with several, often five or more, simultaneously. Hypertension layered over type 2 diabetes. Heart failure compounded by chronic kidney disease and depression. Osteoporosis alongside dementia and chronic pain.

This phenomenon—known clinically as multimorbidity—is not an edge case. It is the standard presentation for older patients in hospitals, outpatient clinics, and primary care practices around the world. And it represents one of the most urgent, complex problems in contemporary medicine.

The International Association of Gerontology and Geriatrics (IAGG), founded in 1950, has spent decades building the evidence base, clinical frameworks, and global networks needed to address this challenge. Understanding how IAGG approaches multimorbidity in older adults reveals not just the priorities of one organization, but the direction that geriatric medicine as a whole must take.

What Is Multimorbidity and Why Does It Demand a Different Approach?

Multimorbidity is defined as the presence of two or more chronic conditions in the same individual. While the clinical definition is relatively simple, its implications for healthcare delivery are profound. Standard medical training and clinical practice guidelines have historically been built around single diseases. A cardiologist’s protocol for managing heart failure is developed and validated in patients whose primary diagnosis is heart failure—not in patients who also have advanced renal impairment, frailty, cognitive decline, and a 14-medication prescription list.

This mismatch between how medicine is organized and what older patients actually need is at the core of the multimorbidity challenge. IAGG research consistently highlights that disease-specific guidelines, when applied to older adults with multiple conditions, can conflict directly with one another. Treatments that are evidence-based for one condition may aggravate another. Diagnostic targets appropriate for a 55-year-old with a single disease may be harmful, even dangerous, when applied to an 82-year-old with six.

What IAGG has long argued is that multimorbidity is not simply a more complicated version of single-disease medicine. It is a fundamentally different clinical problem requiring a fundamentally different clinical model.

IAGG’s Core Framework: Treating the Person, Not the Disease List

The International Association of Gerontology and Geriatrics has consistently championed a philosophy of care that centers the older adult as a whole person rather than a set of diagnoses to be individually managed. This approach shapes every dimension of IAGG’s clinical and research agenda on multimorbidity.

Person-Centered Care as a Clinical Imperative

Person-centered care, as IAGG frames it, is not a soft concept or a patient satisfaction strategy—it is a clinical necessity when managing older adults with complex, overlapping conditions. In multimorbidity, treatment decisions routinely involve genuine trade-offs. Tightly controlling blood glucose may increase hypoglycemic risk in a patient prone to falls. Anticoagulation therapy may be indicated for atrial fibrillation but carries serious bleeding risk in someone who falls regularly due to Parkinson’s disease. Aggressive blood pressure management may protect the heart while reducing cerebral perfusion in a patient with vascular dementia.

According to IAGG, navigating these trade-offs cannot be done by applying guidelines in isolation. It requires understanding what the patient values most—continued independence, reduction of pain, staying out of hospital, maintaining the capacity to engage with family—and aligning care priorities accordingly. IAGG highlights that this is not a departure from evidence-based medicine. It is how evidence-based medicine should be practiced in the reality of geriatric populations.

The Comprehensive Geriatric Assessment

Among the most important tools in IAGG’s clinical toolkit is the Comprehensive Geriatric Assessment (CGA). The CGA is a structured, multidimensional evaluation that examines an older adult across domains that a standard medical consultation rarely touches: cognitive function, psychological status, functional ability, nutritional state, medication burden, social support structures, and environmental circumstances.

IAGG has long positioned the CGA as the gold standard for evaluating older adults with complex needs, and research supports this strongly. Studies have shown that CGA-guided care is associated with reduced mortality, lower rates of hospital admission, and improved functional outcomes in older patients. For individuals living with multiple chronic conditions, the CGA offers something that disease-specific assessments cannot: a complete picture of how conditions and circumstances interact, and a basis for setting realistic, individualized care goals.

IAGG advocates for CGA to be embedded into standard care pathways for older adults with multimorbidity—not reserved only for those in the most critical situations, but applied proactively as part of routine geriatric practice.

Chronic Conditions Most Commonly Addressed in IAGG’s Multimorbidity Research

IAGG’s research and clinical guidance address a broad spectrum of conditions, but certain combinations appear with particular frequency in older adults and require coordinated management strategies. The table below outlines the most commonly encountered chronic conditions in multimorbid older patients, the conditions with which they most often co-occur, and the specific clinical management challenges each pairing presents.

Chronic Condition Common Co-occurring Conditions Primary Management Challenge
Type 2 Diabetes Cardiovascular disease, chronic kidney disease, depression Glycemic targets must be individualized; medication dosing is constrained by renal function; depression worsens self-management capacity
Heart Failure COPD, chronic kidney disease, atrial fibrillation, anemia Fluid management and drug interactions require balancing across multiple systems simultaneously
Dementia Depression, hypertension, diabetes, falls, urinary incontinence Cognitive impairment affects consent, medication adherence, symptom reporting, and capacity for shared decision-making
Osteoarthritis Depression, obesity, cardiovascular disease, chronic pain Standard analgesics carry cardiovascular and renal risks; reduced mobility accelerates decline in comorbid conditions
Depression Diabetes, heart disease, chronic pain, dementia, COPD Frequently underdetected in older adults; bidirectionally worsens outcomes in most physical conditions
Chronic Kidney Disease Hypertension, diabetes, cardiovascular disease, anemia Restricts the use of many medications standard in other conditions; accelerates cardiovascular risk

These combinations illustrate why no single clinician or specialty can comprehensively manage multimorbidity alone. Each pairing demands an understanding of how conditions interact physiologically, pharmacologically, and functionally—the kind of integrative thinking that IAGG consistently champions through its research and educational frameworks.

Polypharmacy: One of the Most Urgent Challenges IAGG Identifies

Polypharmacy—generally defined as the concurrent use of five or more medications—is, in many respects, a predictable consequence of uncoordinated multimorbidity management. When each chronic condition generates its own prescriptions, often from different specialists with limited visibility into each other’s decisions, medication lists can compound rapidly. It is not unusual for an older adult with multiple chronic conditions to be managing ten, twelve, or more medications simultaneously.

IAGG has repeatedly highlighted polypharmacy as one of the most serious and underappreciated risks in geriatric care. Age-related changes in physiology alter how medications are absorbed, distributed, metabolized, and eliminated. The kidneys filter less efficiently. Liver metabolism slows. Body composition shifts, affecting drug distribution. These changes mean that doses appropriate for younger adults may accumulate to toxic levels in older patients. Drug-drug interactions multiply with each addition to the prescription list. Adverse drug reactions are a leading cause of hospitalizations in older adults worldwide.

The approach IAGG supports involves systematic, evidence-guided medication review as an ongoing component of geriatric care—not a one-time event but a regular process. This review considers each medication in the context of the patient’s complete clinical picture, current goals of care, and functional status. Structured tools such as the STOPP/START criteria and the Beers Criteria, both widely used in geriatric practice, align closely with the rational deprescribing philosophy that IAGG research endorses. Reducing inappropriate medications is not a compromise in care—it is frequently its improvement.

Global Knowledge-Sharing: How IAGG Builds a Worldwide Response

What distinguishes IAGG from many national medical organizations is its structure as a genuinely global network. The International Association of Gerontology and Geriatrics operates through five regional associations—covering Africa, Asia/Oceania, Europe, Latin America, and North America—each connecting national member societies with each other and with the broader international community of gerontologists and geriatricians.

This structure creates a powerful mechanism for the cross-pollination of research and clinical experience. Insights from longitudinal aging studies in Asia can inform care model development in Latin America. Policy frameworks tested in European health systems can be adapted and evaluated in African contexts. IAGG functions as the connective tissue that makes this knowledge transfer possible across language, geography, and health system differences.

The IAGG World Congress, convened every four years, serves as the central gathering point for this global exchange. Researchers, clinicians, and policymakers present their findings, debate approaches to shared challenges, and collectively advance the field. Multimorbidity has become an increasingly central theme across these congresses, reflecting its growing importance in aging populations worldwide.

IAGG has also engaged with the World Health Organization and other international bodies on frameworks for integrated care and healthy aging, giving the organization influence at the policy level where systemic change begins.

Strengthening the Geriatric Workforce: Education as a Priority

No clinical framework for managing multimorbidity will improve outcomes if the healthcare workforce lacks the training to implement it. This is a reality that IAGG takes seriously, particularly given the global shortage of geriatric specialists relative to the scale of the aging population. The majority of older adults with multiple chronic conditions are seen, at least initially, by primary care providers, nurses, and non-specialist physicians who may have had limited formal training in geriatric principles.

IAGG has consistently supported efforts to integrate geriatric medicine competencies into undergraduate and postgraduate medical and nursing curricula globally. The goal is not to transform all clinicians into geriatric specialists, but to ensure that core geriatric principles—comprehensive assessment, functional outcome prioritization, medication review, person-centered planning—become embedded in the practice of clinicians at every level.

This educational mission is especially critical in low- and middle-income countries, where specialist geriatric services are often severely limited even as the proportion of older adults grows rapidly. IAGG’s regional networks play a direct role in facilitating capacity-building and knowledge transfer across these contexts, recognizing that the multimorbidity challenge is not confined to wealthy nations with well-resourced health systems.

Evidence-Informed Strategies for Multimorbidity Management

Across IAGG’s research outputs, position statements, and educational initiatives, a clear set of practical strategies emerges for clinicians and health systems aiming to improve outcomes for older adults with multiple chronic conditions. These are not untested ideals—they are evidence-informed approaches refined through decades of international geriatric research and clinical practice.

The following strategies appear consistently in frameworks aligned with IAGG’s clinical and research priorities:

  • Implement Comprehensive Geriatric Assessment routinely for older adults with complex multimorbidity, not only at acute presentation but as part of ongoing care planning and annual review cycles.
  • Individualize treatment targets rather than applying single-disease guidelines uniformly. A patient’s functional capacity, life expectancy, cognitive status, and personal priorities must inform what constitutes appropriate management for them.
  • Prioritize functional outcomes and quality of life as primary care goals, recognizing that these matter as much as—and in some cases more than—biomarker optimization.
  • Conduct regular, structured medication reviews to identify polypharmacy, inappropriate prescribing, drug-drug interactions, and opportunities for rational deprescribing.
  • Build and sustain multidisciplinary care teams involving physicians, pharmacists, nurses, physiotherapists, social workers, and other relevant specialists with shared care plans and clear communication protocols.
  • Engage patients and caregivers meaningfully in all care decisions, including honest, compassionate discussions about trade-offs, priorities, and the goals that matter most to the individual.
  • Assess social and environmental determinants of health as part of standard clinical care—housing stability, caregiver capacity, nutritional access, and social connection are not secondary concerns but primary drivers of health outcomes in older adults.
  • Plan proactively for care transitions—between hospital and community, between specialist and primary care—as these moments represent the highest risk for patients with complex multimorbidity and require active coordination, not passive handover.

Together, these strategies represent a coherent and clinically grounded model of care—one that asks health systems to move from reactive, disease-specific responses to proactive, integrated, and deeply individualized approaches to aging. IAGG’s sustained advocacy for this model has been central to building both the evidence and the professional consensus needed to make it a clinical standard rather than an aspiration.

Conclusion

Managing multiple chronic conditions in older adults is one of the most consequential and complex challenges facing healthcare systems globally. It will deepen in urgency as demographic aging accelerates in every region of the world. The International Association of Gerontology and Geriatrics (IAGG) has spent more than seven decades building the research, frameworks, networks, and workforce needed to meet this challenge—and its influence on how the world thinks about geriatric care is profound.

What ultimately defines IAGG’s approach is not any single clinical tool or guideline, but a consistent commitment to treating older adults as whole people whose needs, values, and circumstances must shape every care decision. By championing comprehensive assessment, person-centered planning, rational medication management, multidisciplinary collaboration, and global knowledge-sharing, IAGG provides both a scientific foundation and a moral compass for modern geriatric medicine.

As populations age and multimorbidity becomes ever more prevalent, the principles that International Association of Gerontology and Geriatrics has worked to establish—rigorous, humane, and genuinely integrated care for older adults—are not just best practice. They are the path forward for health systems that want to serve their aging populations well.

Similar Posts

  • OUR MISSION

    iagg

    OUR MISSION The mission of the International Association of Gerontology and Geriatrics is to promote the highest levels of achievement in gerontological research and training worldwide, and to interact with other international, inter-governmental and non-governmental organizations in the promotion of gerontological interests globally and on behalf of its member associations. The Association pursues these activities…

  • Workshops

    iagg

    With the support of the IAGG, WHO – World Health Organization (http://who.int/ageing) and the SFGG – French Society of Geriatrics and Gerontology (http://www.sfgg.fr) four different workshops will be organized throughout this mandate. Fifteen worldwide experts and 15 international observers will get together to define recommendations and their related program project. The high level work be presented at…

  • Next World Congress in 2013

    iagg

    Next World Congress in 2013 23 Jun 2013 – 27 Jun 2013Seoul KOREA Seoul will host IAGG’s 20th World Congress from June 23-27, 2013. The largest international congress of the kind will bring together leading gerontologists, geriatrics scholars, policy decision-makers, professional activists, related companies, and researchers. Note the important dates : * Call for Submitted Symposia: September…

  • IAGG News

    iagg

    2015.06.17 11:00 International Federation on Ageing 13th Global Conference, Disasters in an Ageing World: Readiness, Resilience and Recovery. The Conference will be held at the Brisbane Convention & Exhibition Centre from Tuesday 21st – Thursday 23rd June 2016. Admin Views 3770 Votes 0 Comment 0 + – Up Down Comment Print Files International Federation on…